Quantcast

Latest Pulmonology Stories

2014-01-27 16:25:06

WINSTON-SALEM, N.C., Jan. 27, 2014 /PRNewswire-USNewswire/ -- More than 25 million people in the United States have asthma, a chronic lung disease that inflames and narrows the airways causing recurring periods of wheezing, chest tightness, shortness of breath and coughing. (Logo: http://photos.prnewswire.com/prnh/20111114/DC06171LOGO) Although several types of drugs are available to treat asthma, long-acting beta agonists (LABAs) are among the most commonly used and work well for...

2014-01-27 14:57:08

More than 25 million people in the United States have asthma, a chronic lung disease that inflames and narrows the airways causing recurring periods of wheezing, chest tightness, shortness of breath and coughing. Although several types of drugs are available to treat asthma, long-acting beta agonists (LABAs) are among the most commonly used and work well for most people. However, for a small subgroup of people with asthma, LABAs can cause severe, life-threatening side effects and carry a...

2014-01-24 11:50:33

The Annals of the American Thoracic Society has released a comprehensive supplement on the 56th annual Thomas L. Petty Aspen Lung Conference entitled "The Lung Microbiome: A New Frontier in Pulmonary Medicine." More than 170 microbiologists, basic respiratory scientists, and pulmonary clinicians traveled from nine countries to convene at the three-day conference, which took place in June 2013 in Aspen, CO. Research from 12 state-of-the-art speakers, 24 oral research presentations, and 20...

2014-01-23 04:21:29

OXFORD, England, January 23, 2014 /PRNewswire/ -- First clinical data from PSX1002, a novel, orally inhaled, drug-only, pMDI suspension formulation of glycopyrronium bromide, a long-acting muscarinic antagonist (LAMA) Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with...

2014-01-20 12:24:00

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Summary GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 -...

2014-01-14 12:26:46

BETHESDA, Md., Jan. 14, 2014 /PRNewswire/ -- Evidera, a leading provider of evidence-based solutions for the healthcare industry, announced that the Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, has released its first draft qualification guidance document for a patient-reported outcome (PRO) measure in drug development: Qualification of Exacerbations of Chronic Pulmonary Disease Tool [EXACT] for Measurement of Symptoms of Acute Bacterial...

2014-01-13 16:25:12

-- Ultibro(TM) Breezhaler®1(QVA149), a long-term once-daily dual bronchodilator, received Health Canada approval on December 23rd 2013 for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema -- Pivotal Phase III IGNITE data showed QVA149 significantly improved lung function and patient-reported outcomes including...

2014-01-09 08:27:20

- Q4'13 revenue of $25.6 million represents ninth consecutive quarter of Esbriet growth - BRISBANE, Calif., Jan. 9, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced unaudited revenue for the fourth quarter and year ended December 31, 2013. The company also provided updated 2013 expense guidance, highlighted recent progress in its commercial and other business activities and provided forward-looking guidance for 2014 revenue and expenses. (Logo:...

2014-01-08 23:24:26

The new “Tips For A Healthy Respiratory System” report on the site Vkool.com covers useful tips on how to keep the respiratory system healthy. Seattle, WA (PRWEB) January 08, 2014 The new “Tips For A Healthy Respiratory System” on the website Vkool.com delivers to people tips on how to keep the respiratory system healthy. This article is actually suitable for those people who want to improve their lung function safely without using any kind of drugs or supplements. Firstly, the...

2014-01-08 12:30:46

ATLANTA, Jan. 8, 2014 /PRNewswire/ -- The Celtaxsys Board of Directors today announced that Greg Duncan has been appointed as President and Chief Executive Officer (CEO) and will join the board of directors effective immediately. Mr. Duncan joins Celtaxsys following his most recent role as an Executive Committee member and President of North America for Brussels based UCB, prior to which he served as a Senior Vice-President at Pfizer where his duties included leading US marketing, as...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »
Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related